Copyright: ©Author(s) 2026.
World J Nephrol. Sep 25, 2026; 15(3): 120870
Published online Sep 25, 2026. doi: 10.5527/wjn.120870
Published online Sep 25, 2026. doi: 10.5527/wjn.120870
Table 5 Follow-up laboratory data of the studied group after two months, mean ± SD
| Lactulose group (n = 50) | LA group (n = 50) | Control group (n = 50) | P value | 1P value | 2P value | 3P value | |
| Hemoglobin (mg/dL) | 10.87 ± 2.11 | 10.90 ± 2.01 | 10.73 ± 2.45 | 0.55 | 0.92 | 0.30 | 0.12 |
| Platelets (103/μL) | 301 ± 66.56 | 312.40 ± 55.67 | 299.02 ± 60.55 | 0.40 | 0.46 | 0.19 | 0.10 |
| Leucocytes (103/μL) | 7.11 ± 1.78 | 7.90 ± 3.09 | 7.09 ± 2.01 | 0.38 | 0.78 | 0.80 | 0.34 |
| Bilirubin (mg/dL) | 1.01 ± 0.21 | 0.98 ± 0.10 | 0.95 ± 0.01 | 0.91 | 0.91 | 0.70 | 0.19 |
| Albumin (g/dL) | 3.38 ± 0.45 | 3.36 ± 0.40 | 3.34 ± 0.99 | 0.50 | 0.65 | 0.88 | 0.50 |
| AST (U/L) | 33.19 ± 4.90 | 36.24 ± 1.09 | 31.57 ± 5.60 | 0.60 | 0.45 | 0.11 | 0.65 |
| ALT (U/L) | 35.67 ± 5.90 | 33.11 ± 5.60 | 39.11 ± 8.01 | 0.10 | 0.22 | 0.50 | 0.89 |
| Urea (mg/dL) | 52.98 ± 1.64 | 53.45 ± 4.98 | 55.60 ± 4.36 | 0.80 | 0.22 | 0.19 | 0.67 |
| Creatinine (mg/dL) | 3.57 ± 1.22 | 4 ± 1.13 | 3.88 ± 1.65 | 0.50 | 0.10 | 0.21 | 0.78 |
| ACR | 119.91 ± 14.56 | 115.06 ± 23.67 | 112.31 ± 19.45 | 0.22 | 0.12 | 0.45 | 0.22 |
| eGFR (mL/minute/1.73 m2) | 49.56 ± 2.59 | 49.89 ± 3.56 | 50.11 ± 7.01 | 0.08 | 0.93 | 0.45 | 0.11 |
| Sodium (mmol/L) | 133.27 ± 0.10 | 133.14 ± 0.37 | 132.45 ± 0.08 | 0.45 | 0.16 | 0.98 | 0.54 |
| Potassium (mmol/L) | 4.01 ± 1.23 | 4.06 ± 1.07 | 3.98 ± 1.01 | 0.21 | 0.09 | 0.10 | 0.42 |
| Calcium (mg/dL) | 8.90 ± 1.67 | 8.67 ± 2.01 | 9.19 ± 0.56 | 0.56 | 0.31 | 0.98 | 0.12 |
| Magnesium (mmol/L) | 2.07 ± 0.10 | 1.98 ± 0.45 | 2.21 ± 0.60 | 0.21 | 0.56 | 0.88 | 0.91 |
| Phosphorus (mmol/L) | 4.76 ± 0.61 | 5.09 ± 1.22 | 4.20 ± 0.56 | 0.40 | 0.23 | 0.11 | 0.59 |
| RBS (mg/dL) | 210.11 ± 4.35 | 209.1 ± 55.52 | 219.45 ± 27.90 | 0.10 | 0.19 | 0.40 | 0.86 |
| HbA1C (%) | 6.90 ± 1.25 | 7.14 ± 0.48 | 7.22 ± 0.19 | 0.08 | 0.20 | 0.18 | 0.50 |
| Cholesterol (mg/dL) | 231.56 ± 24.11 | 234.18 ± 44.99 | 230.11 ± 23.19 | 0.09 | 0.29 | 0.40 | 0.21 |
| Triglycerides (mg/dL) | 134.56 ± 28.67 | 132.88 ± 17.90 | 130.65 ± 22.19 | 0.44 | 0.13 | 0.63 | 0.87 |
| LDL (mg/dL) | 145.67 ± 24.11 | 140.56 ± 34.60 | 130.05 ± 33.01 | 0.08 | 0.17 | 0.20 | 0.18 |
| HDL (mg/dL) | 49.11 ± 7.01 | 50.47 ± 5.60 | 48.56 ± 6.90 | 0.07 | 0.08 | 0.30 | 0.19 |
- Citation: Mubarak AS, Elshazly A, Mokhtar A, Gadelkareem RA, Azoz NM. Lactulose vs Lactobacillus acidophilus for patients with chronic kidney disease: A randomized controlled trial. World J Nephrol 2026; 15(3): 120870
- URL: https://www.wjgnet.com/2220-6124/full/v15/i3/120870.htm
- DOI: https://dx.doi.org/10.5527/wjn.120870